Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3767258 | 0.72 | — | — | |
| SCHEMBL7682777 | 0.71 | — | — | |
| SCHEMBL27793686 | 0.67 | — | — | |
| Acetamide SCHEMBL27912538 | 0.64 | LMNA (0.38) | — | |
| SCHEMBL6954369 | 0.60 | MEN1 (0.43) | — | |
| SCHEMBL28475451 | 0.60 | — | — | |
| SCHEMBL1395778 | 0.59 | CYP3A4 (0.68) | — | |
| SCHEMBL9017019 | 0.58 | — | — | |
| SCHEMBL5912859 | 0.58 | CAPN1 (0.34) | — | |
| SCHEMBL11468155 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6657069-B2 | Reacting 6-aminocarbonylmethyl-4H-2,3- dioxin-4-one compound with alcohol or water to produce 3-oxopentanedicarboxylic acid amide esters; decyclization | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-12-02 | — | — | US | disclosed |
| US-20030130519-A1 | Amido compounds and process for producing the same | DAICEL CHEMICAL INDUSTRIES, LTD. | 2003-07-10 | — | — | US | disclosed |
| US-6548674-B2 | 6-aminocarbonylmethyl-4H-1,3-dioxin-4-ones made by reacting a 6-halomethyl-4H-1,3-dioxin-4-ones with primary or secondary amine and carbon monoxide; intermediate to 3-oxopentanedicarboxylic acid amides for drugs, polyamides | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-04-15 | — | — | US | disclosed |
| US-20010023297-A1 | Amido compounds and process for producing the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-09-20 | — | — | US | disclosed |
| EP-1132386-A1 | Amido compounds and process for producing the same | Daicel Chemical Industries, Ltd. (JP) | 2001-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130519-A1 | Amido compounds and process for producing the same | PAM, HAAO, DAO | CA2 83/4885 |
| US-20010023297-A1 | Amido compounds and process for producing the same | PAM, HAAO, DAO | CA2 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.